Episode 6: Why is Women’s Health a Strategic Imperative for Employers?

March 24, 2025

Women’s health is not just a healthcare issue—it’s a business priority. In this episode of NEBGH Voices, we sit down with Elizabeth Bailey, Co-Founder & Managing Partner at Foreground Capital, to explore why investing in women’s health drives better outcomes for employees and employers alike. From market growth to workplace impact, tune in for expert insights on the future of women’s healthcare benefits and innovation.

NEBGH Voices is produced by: Deren Abrams, Adria Subbiondo, and Christian Waugh

Guests

Elizabeth Bailey

Co-Founder & Managing Partner

Elizabeth Bailey has over 20 years of experience in venture capital and supporting early-stage healthcare companies. She is currently a Co-founder and Managing Partner at Foreground Capital, a venture capital fi rm investing in early-stage women’s health start-ups. Elizabeth co-founded and led Foreground’s precursor funds at RH Capital, where she and her team built one of the largest dedicated venture capital portfolios in women’s health. At Foreground Capital, she continues to manage RH Capital funds and serves as a board director for Raydiant Oximetry and Testmate Health, and as a board observer for Bloomlife, Cayaba, Mae and Twentyeight Health.

Elizabeth was previously a Partner at Commons Capital, one of the fi rst impact investment funds, where she managed the healthcare portfolio, including Claros Diagnostics (acquired by OPKO), CodeRyte (acquired by 3M), HistoRx (acquired by Genoptix), Medical Metrx Solutions (acquired by AIG) and TelaDoc (IPO: TDOC).

She holds a Masters in Public Policy from Harvard Kennedy School and a BA from Brown University. Throughout her career, Elizabeth has been a strong advocate of the power of business to drive social change. She has been named twice as a Trailblazing Leader in Women’s Health and received the inaugural FemForce Vanguard Award for her leadership in women’s health.